+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Beta Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Renin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Renin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
VAP-1 Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

VAP-1 Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cholesterol Absorption Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cholesterol Absorption Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
PDE 1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

PDE 1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
PDE Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

PDE Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Beta-2 Receptors Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-2 Receptors Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Glycan Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Glycan Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Aldosterone Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Aldosterone Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Angiotensin Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Angiotensin Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more